Search Within

Hikmat Al-Ahmadie

  1. "Jonathan Rosenberg"
Formats
  1. Meeting Abstract (84)
  2. Journal Article (46)
  3. Review (3)
  4. Correspondence (1)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (136)
  2. Department of Pathology and Laboratory Medicine (136)
  3. Genitourinary Oncology Service (136)
  4. Solid Tumor Oncology Division (136)
  5. GSK Faculty (107)
  6. Human Oncology and Pathogenesis Program (105)

More Groups

People
  1. Jonathan Rosenberg (136)
  2. Gopakumar Iyer (123)
  3. Dean Bajorin (113)
  4. David Solit (99)
  5. Bernard Bochner (95)
  6. Michael Berger (64)

More People

Years
  1. 2025 (9)
  2. 2024 (9)
  3. 2023 (7)
  4. 2022 (16)
  5. 2021 (12)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (48)
  2. Modern Pathology (13)
  3. Laboratory Investigation (12)
  4. Cancer Research (11)
  5. European Urology (8)
  6. Clinical Cancer Research (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (51)
  2. Nature Publishing Group (22)
  3. American Association for Cancer Research (20)
  4. Nature Research (13)
  5. Elsevier Science, Inc. (8)
  6. Elsevier Inc. (7)

More Publishers

Results (136)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modulating the PPARĪ³ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer
    Journal Article

    Chang, K.; Delavan, H. M.; Yip, E.; Kasap, C.; Zhu, J.; Lodha, R.; Liao, S. Y.; Berman, S. C.; Carretero-Gonzalez, A.; Basar, M.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Clinical outcomes, genomic heterogeneity, and therapeutic considerations across histologic subtypes of urothelial carcinoma
    Journal Article

    Chu, C. E.; Chen, Z.; Whiting, K.; Ostrovnaya, I.; Lenis, A. T.; Clinton, T. N.; Rammal, R.; Ozcan, G. G.; Akbulut, D.; Basar, M.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Comprehensive molecular, pathological, and clinical characterization of clear cell adenocarcinoma of the urinary tract
    Journal Article

    Rammal, R.; Koll, F. J.; Chen, Z.; Tallman, J. E.; Alam, S. M.; Eichholz, J. E.; Chatila, W.; Agbamu, T.; Lenis, A. T.; Basar, M.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Relationship among DNA damage response gene alterations, molecular subtypes, and survival outcomes in patients with metastatic bladder cancer treated on CALGB 90601
    Journal Article

    Iyer, G.; Choi, W.; Luo, B.; Carvalho, F.; Hanlon, T.; Reis, H.; Guercio, B. J.; Fong, M.; Mountain, J.; Feng, M.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Updated long-term follow-up from a phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Jayalath, V.; Teo, M. Y.; Assel, M.; Rodriguez, D.; Meyerson, A.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Correlation of NECTIN4 amplification and expression with response to enfortumab vedotin (EV) treatment in locally advanced or metastatic urothelial carcinoma
    Meeting Abstract

    Yol, C.; Irawan, H.; Sternschuss, M.; Gupta, A.; Bent, E.; Basar, M.; Chen, J. F.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Transcriptional analysis of bladder cancer histologic subtypes reveals novel drug target heterogeneity
    Meeting Abstract

    Tallman, J. E.; Kuo, F.; Koll, F.; Alam, S. M.; Basar, M.; Luo, J.; Gao, S. P.; Tang, X.; Yol, C.; Gokturk, G.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Molecular heterogeneity and immune infiltration drive clinical outcomes in upper tract urothelial carcinoma
    Journal Article

    Kim, K.; Alam, S. M.; Kuo, F.; Chen, Z.; Yip, W.; Katims, A. B.; Chu, C.; Lenis, A. T.; Hu, W.; Gokturk Ozcan, G.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Loss of KMT2C or KMT2D primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters
    Journal Article

    Wang, N.; Pachai, M. R.; Li, D.; Lee, C. J.; Warda, S.; Khudoynazarova, M. N.; Cho, W. H.; Xie, G.; Shah, S. R.; Yao, L.; more...
    Nature Genetics (2025)

    Fulltext@MSK | Save
  • HER2 and PD-L1 immunohistochemistry (IHC) expression, and HER2 genomic alterations: Associations and clinical outcomes for advanced bladder cancer
    Meeting Abstract

    Aggen, D. H.; Shah, N. J.; Zheng, J.; Alam, S. M.; Balar, O.; Niederhausern, A.; Regazzi, A. M.; Ratna, N.; Funt, S. A.; Teo, M. Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save